University of British Columbia: Psychotic Disorders trials

The registry lists 15 Psychotic Disorders studies with University of British Columbia as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 3Phase 4 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Music Study in Refractory PsychosisStatus unknownNCT02431949
• The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis DisorderStatus unknownNCT02322918
• Study of the Effect of Dosing on Clozapine LevelsWithdrawnNCT02286206Phase 4
• Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric MedicationsWithdrawnNCT02213887Phase 4
• Serial Comparisons of Abdominal and Neurological MRI ScansStatus unknownNCT02009969
• Contrasting Group Therapy Methods for PsychosisTerminatedNCT01764568Not applicable
• Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders?Status unknownNCT01752465Not applicable
• Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRICompletedNCT01739127
• Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental IllnessCompletedNCT00714818Phase 3
• Impact of Genetic Counseling for Individuals With Mental IllnessCompletedNCT00713804Phase 3
• Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)WithdrawnNCT00702793Phase 4
• Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art InterventionsCompletedNCT00358709Phase 3
• Risperidone LA Heathcare Resource StudyCompletedNCT00272597Phase 4
• CARE Study: Improving Treatment for the Most Severely Ill With SchizophreniaCompletedNCT00272584Phase 4
• V3: Vancouver-Victoria Valacyclovir Trial for Early PsychosisCompletedNCT00175513Phase 2